Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Feb 16, 2023, after the close
10-K filed Feb 28, 2023, 59 days after period end · 0001299130-23-000032
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 |
|---|---|---|---|---|
| Revenue | $27.35M | $36.02M | $25.13M | $27.93M |
| Net Income | -$84.38M | -$69.33M |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| $74.94M |
| -$91.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
